{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T05:49:10Z","timestamp":1773985750701,"version":"3.50.1"},"reference-count":34,"publisher":"Public Library of Science (PLoS)","issue":"4","license":[{"start":{"date-parts":[[2021,4,16]],"date-time":"2021-04-16T00:00:00Z","timestamp":1618531200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Roche Pharma AG"},{"name":"Roche Pharma AG"},{"DOI":"10.13039\/501100001646","name":"Robert Bosch Stiftung","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001646","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001646","name":"Robert Bosch Stiftung","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001646","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014837","name":"Rudolf-Ackermann-Stiftung","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100014837","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:sec id=\"sec001\">\n<jats:title>Background<\/jats:title>\n<jats:p>Cytomegalovirus (CMV) infection is amongst the most important factors complicating solid organ transplantation. In a large prospective randomized clinical trial, valganciclovir prophylaxis reduced the occurrence of CMV infection and disease compared with preemptive therapy in CMV-positive renal allograft recipients (VIPP study; NCT00372229). Here, we present a subanalysis of the VIPP study, investigating single nucleotide polymorphisms (SNPs) in immune-response-related genes and their association with active CMV infection, CMV disease, graft loss or death, rejection, infections, and leukopenia.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec002\">\n<jats:title>Methods<\/jats:title>\n<jats:p>Based on literature research ten SNPs were analyzed for <jats:italic>TLR4<\/jats:italic>, three for <jats:italic>IFN-\u03b3<\/jats:italic>, six for <jats:italic>IL10<\/jats:italic>, nine for <jats:italic>IL37<\/jats:italic>, and two for <jats:italic>TNF-\u03b1<\/jats:italic>. An asymptotic independence test (Cochran-Armitage trend test) was used to examine associations between SNPs and the occurrence of CMV infection or other negative outcomes. Statistical significance was defined as p&lt;0.05 and Bonferroni correction for multiple testing was performed.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec003\">\n<jats:title>Results<\/jats:title>\n<jats:p>SNPs were analyzed on 116 blood samples. No associations were found between the analyzed SNPs and the occurrence of CMV infection, rejection and leukopenia in all patients. For <jats:italic>IL37<\/jats:italic> rs2723186, an association with CMV disease (p = 0.0499), for <jats:italic>IL10<\/jats:italic> rs1800872, with graft loss or death (p = 0.0207) and for <jats:italic>IL10<\/jats:italic> rs3024496, with infections (p = 0.0258) was observed in all patients, however did not hold true after correction for multiple testing.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec004\">\n<jats:title>Conclusion<\/jats:title>\n<jats:p>The study did not reveal significant associations between the analyzed SNPs and the occurrence of negative outcomes in CMV-positive renal transplant recipients after correction for multiple testing. The results of this association analysis may be of use in guiding future research efforts.<\/jats:p>\n<\/jats:sec>","DOI":"10.1371\/journal.pone.0246118","type":"journal-article","created":{"date-parts":[[2021,4,16]],"date-time":"2021-04-16T18:30:41Z","timestamp":1618597841000},"page":"e0246118","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":3,"title":["No association of genetic variants in TLR4, TNF-\u03b1, IL10, IFN-\u03b3, and IL37 in cytomegalovirus-positive renal allograft recipients with active CMV infection\u2014Subanalysis of the prospective randomised VIPP study"],"prefix":"10.1371","volume":"16","author":[{"given":"Pascale","family":"Mazzola","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elke","family":"Schaeffeler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oliver","family":"Witzke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Nitschke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Volker","family":"Kliem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Max","family":"Zortel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eva-Maria","family":"Wagner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9984-075X","authenticated-orcid":true,"given":"Matthias","family":"Schwab","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ingeborg A.","family":"Hauser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2021,4,16]]},"reference":[{"issue":"6","key":"pone.0246118.ref001","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1097\/TP.0000000000002191","article-title":"The Third International Consensus Guidelines on the Management of Cytomegalovirus in Solid-organ Transplantation","volume":"102","author":"C.N. Kotton","year":"2018","journal-title":"Transplantation"},{"issue":"Suppl 2","key":"pone.0246118.ref002","doi-asserted-by":"crossref","first-page":"S192","DOI":"10.21037\/tau.2018.10.14","article-title":"Cytomegalovirus infection in kidney allografts: a review of literature","volume":"8","author":"G.F. Morgantetti","year":"2019","journal-title":"Transl Androl Urol"},{"issue":"8","key":"pone.0246118.ref003","doi-asserted-by":"crossref","first-page":"e13339","DOI":"10.1111\/ctr.13339","article-title":"Cytomegalovirus infection and graft rejection as risk factors for pneumocystis pneumonia in solid organ transplant recipients: A systematic review and meta-analysis","volume":"32","author":"S.M. Hosseini-Moghaddam","year":"2018","journal-title":"Clin Transplant"},{"issue":"8","key":"pone.0246118.ref004","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1093\/cid\/ciy682","article-title":"A Multicenter Case-control Study of the Effect of Acute Rejection and Cytomegalovirus Infection on Pneumocystis Pneumonia in Solid Organ Transplant Recipients","volume":"68","author":"S.M. Hosseini-Moghaddam","year":"2019","journal-title":"Clin Infect Dis"},{"issue":"1","key":"pone.0246118.ref005","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1186\/s12879-017-2599-y","article-title":"Cytomegalovirus viraemia and mortality in renal transplant recipients in the era of antiviral prophylaxis. Lessons from the western Australian experience","volume":"17","author":"L.A. Selvey","year":"2017","journal-title":"BMC Infect Dis"},{"issue":"2","key":"pone.0246118.ref006","doi-asserted-by":"crossref","first-page":"ofz003","DOI":"10.1093\/ofid\/ofz003","article-title":"Correlation of Cytomegalovirus (CMV) Disease Severity and Mortality With CMV Viral Burden in CMV-Seropositive Donor and CMV-Seronegative Solid Organ Transplant Recipients","volume":"6","author":"J.M. McBride","year":"2019","journal-title":"Open Forum Infect Dis"},{"issue":"5","key":"pone.0246118.ref007","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1002\/jmv.23539","article-title":"High risk of cytomegalovirus infection following solid organ transplantation despite prophylactic therapy","volume":"85","author":"H. Harvala","year":"2013","journal-title":"J Med Virol"},{"key":"pone.0246118.ref008","unstructured":"Roche Pharma (2019). Valcyte\u00ae summary of product characteristics; https:\/\/www.medicines.org.uk\/emc\/medicine\/9315. Accessed November 2020."},{"issue":"1","key":"pone.0246118.ref009","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1097\/TP.0b013e318238dab3","article-title":"Valganciclovir prophylaxis versus preemptive therapy in cytomegalovirus-positive renal allograft recipients: 1-year results of a randomized clinical trial","volume":"93","author":"O. Witzke","year":"2012","journal-title":"Transplantation"},{"issue":"5","key":"pone.0246118.ref010","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1097\/TP.0000000000002024","article-title":"Valganciclovir Prophylaxis Versus Preemptive Therapy in Cytomegalovirus-Positive Renal Allograft Recipients: Long-term Results After 7 Years of a Randomized Clinical Trial","volume":"102","author":"O. Witzke","year":"2018","journal-title":"Transplantation"},{"issue":"26","key":"pone.0246118.ref011","doi-asserted-by":"crossref","first-page":"12260","DOI":"10.1073\/pnas.92.26.12260","article-title":"Apolipoprotein E4 allele as a predictor of cholinergic deficits and treatment outcome in Alzheimer disease","volume":"92","author":"J. Poirier","year":"1995","journal-title":"Proc Natl Acad Sci U S A"},{"key":"pone.0246118.ref012","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/j.1749-6632.1996.tb32603.x","article-title":"Apolipoprotein E genotype and gender influence response to tacrine therapy","volume":"802","author":"M.R. Farlow","year":"1996","journal-title":"Ann N Y Acad Sci"},{"issue":"9051","key":"pone.0246118.ref013","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/S0140-6736(97)80089-X","article-title":"APOE genotyping and response to drug treatment in Alzheimer\u2019s disease","volume":"349","author":"F. Richard","year":"1997","journal-title":"Lancet"},{"issue":"2","key":"pone.0246118.ref014","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1056\/NEJM199801083380203","article-title":"The role of a common variant of the cholesteryl ester transfer protein gene in the progression of coronary atherosclerosis. The Regression Growth Evaluation Statin Study Group","volume":"338","author":"J.A. Kuivenhoven","year":"1998","journal-title":"N Engl J Med"},{"issue":"6","key":"pone.0246118.ref015","doi-asserted-by":"crossref","first-page":"2454","DOI":"10.1111\/j.1523-1755.2005.00354.x","article-title":"Relevance of Toll-like receptor-4 polymorphisms in renal transplantation","volume":"67","author":"D. Ducloux","year":"2005","journal-title":"Kidney Int"},{"issue":"5","key":"pone.0246118.ref016","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1128\/JCM.44.5.1847-1850.2006","article-title":"Polymorphisms in the genes encoding chemokine receptor 5, interleukin-10, and monocyte chemoattractant protein 1 contribute to cytomegalovirus reactivation and disease after allogeneic stem cell transplantation","volume":"44","author":"J. Loeffler","year":"2006","journal-title":"J Clin Microbiol"},{"issue":"5","key":"pone.0246118.ref017","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1111\/tid.12285","article-title":"Interferon-gamma gene polymorphism +874 A\/T is associated with an increased risk of cytomegalovirus infection among Hispanic renal transplant recipients","volume":"16","author":"D. Vu","year":"2014","journal-title":"Transpl Infect Dis"},{"issue":"5","key":"pone.0246118.ref018","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1080\/00365549850161403","article-title":"Resistance to human cytomegalovirus infection may be influenced by genetic polymorphisms of the tumour necrosis factor-alpha and interleukin-1 receptor antagonist genes","volume":"30","author":"M. Hurme","year":"1998","journal-title":"Scand J Infect Dis"},{"issue":"40","key":"pone.0246118.ref019","doi-asserted-by":"crossref","first-page":"16711","DOI":"10.1073\/pnas.1111982108","article-title":"Interleukin 37 expression protects mice from colitis","volume":"108","author":"E.N. McNamee","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"pone.0246118.ref020","volume-title":"R: A language and environment for statistical computing","author":"R Core Team","year":"2020"},{"key":"pone.0246118.ref021","author":"JP Sinnwell","year":"2020","journal-title":"haplo.stats: Statistical Analysis of Haplotypes with Traits and Covariates when Linkage Phase is Ambiguous"},{"issue":"6","key":"pone.0246118.ref022","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.humimm.2018.03.009","article-title":"Lack of evidence of association between IFNG and IL28B polymorphisms and QuantiFERON-CMV test results in seropositive transplant patients","volume":"79","author":"R. Aguado","year":"2018","journal-title":"Hum Immunol"},{"issue":"5","key":"pone.0246118.ref023","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.healun.2010.11.008","article-title":"A polymorphism linked to elevated levels of interferon-gamma is associated with an increased risk of cytomegalovirus disease among Caucasian lung transplant recipients at a single center","volume":"30","author":"D. Mitsani","year":"2011","journal-title":"J Heart Lung Transplant"},{"issue":"11","key":"pone.0246118.ref024","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1038\/ni.1944","article-title":"IL-37 is a fundamental inhibitor of innate immunity","volume":"11","author":"M.F. Nold","year":"2010","journal-title":"Nat Immunol"},{"issue":"42","key":"pone.0246118.ref025","doi-asserted-by":"crossref","first-page":"15178","DOI":"10.1073\/pnas.1416714111","article-title":"Suppression of antigen-specific adaptive immunity by IL-37 via induction of tolerogenic dendritic cells","volume":"111","author":"Y. Luo","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"pone.0246118.ref026","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1530\/JME-15-0144","article-title":"Polymorphism of IL37 gene as a protective factor for autoimmune thyroid disease","volume":"55","author":"N. Yan","year":"2015","journal-title":"J Mol Endocrinol"},{"issue":"1","key":"pone.0246118.ref027","doi-asserted-by":"crossref","first-page":"7123","DOI":"10.1038\/s41598-019-42808-4","article-title":"Association between IL-37 gene polymorphisms and risk of HBV-related liver disease in a Saudi Arabian population","volume":"9","author":"M.R. Al-Anazi","year":"2019","journal-title":"Sci Rep"},{"issue":"1","key":"pone.0246118.ref028","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2370.1997.tb00001.x","article-title":"An investigation of polymorphism in the interleukin-10 gene promoter","volume":"24","author":"D.M. Turner","year":"1997","journal-title":"Eur J Immunogenet"},{"issue":"6","key":"pone.0246118.ref029","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1002\/1529-0131(199906)42:6<1101::AID-ANR6>3.0.CO;2-Y","article-title":"Polymorphic haplotypes of the interleukin-10 5\u2019 flanking region determine variable interleukin-10 transcription and are associated with particular phenotypes of juvenile rheumatoid arthritis","volume":"42","author":"E. Crawley","year":"1999","journal-title":"Arthritis Rheum"},{"issue":"23","key":"pone.0246118.ref030","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.1056\/NEJMoa022060","article-title":"Relation of an interleukin-10 promoter polymorphism to graft-versus-host disease and survival after hematopoietic-cell transplantation","volume":"349","author":"M.T. Lin","year":"2003","journal-title":"N Engl J Med"},{"issue":"10","key":"pone.0246118.ref031","doi-asserted-by":"crossref","first-page":"e13384","DOI":"10.1371\/journal.pone.0013384","article-title":"Interleukin-10 (IL-10) pathway: genetic variants and outcomes of HIV-1 infection in African American adolescents","volume":"5","author":"S. Shrestha","year":"2010","journal-title":"PLoS One"},{"issue":"7","key":"pone.0246118.ref032","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1111\/j.1600-6143.2008.02279.x","article-title":"PD-1 expression and IL-2 loss of cytomegalovirus- specific T cells correlates with viremia and reversible functional anergy","volume":"8","author":"U. Sester","year":"2008","journal-title":"Am J Transplant"},{"issue":"6","key":"pone.0246118.ref033","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1093\/cid\/cis993","article-title":"Assessment of cytomegalovirus-specific cell-mediated immunity for the prediction of cytomegalovirus disease in high-risk solid-organ transplant recipients: a multicenter cohort study","volume":"56","author":"O. Manuel","year":"2013","journal-title":"Clin Infect Dis"},{"issue":"9","key":"pone.0246118.ref034","doi-asserted-by":"crossref","first-page":"2505","DOI":"10.1111\/ajt.15315","article-title":"A prospective multicenter observational study of cell-mediated immunity as a predictor for cytomegalovirus infection in kidney transplant recipients","volume":"19","author":"D. Kumar","year":"2019","journal-title":"Am J Transplant"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0246118","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,16]],"date-time":"2021-04-16T18:31:09Z","timestamp":1618597869000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0246118"}},"subtitle":[],"editor":[{"given":"Michael","family":"Nevels","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2021,4,16]]},"references-count":34,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2021,4,16]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0246118","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,16]]}}}